Laura Parkkinen

Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain

Tero Tapiola, Irina Alafuzoff, Sanna‐Kaisa Herukka et al. · Archives of Neurology · 2009 · 880 citations · Full text

Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease

Juliane Neumann, José Brás, Emma Deas et al. · Brain · 2009 · 685 citations · Full text

Alpha‐synuclein <scp>RT</scp>‐Qu<scp>IC</scp> in the <scp>CSF</scp> of patients with alpha‐synucleinopathies

Graham Fairfoul, Lynne I. McGuire, Suvankar Pal et al. · Annals of Clinical and Translational Neurology · 2016 · 591 citations · Full text

Corticobasal Degeneration, Clinical Neurology, Pathology +18

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

Yaroslau Compta, Laura Parkkinen, Sean S. O’Sullivan et al. · Brain · 2011 · 561 citations · Full text

Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

Ruth Chia, Marya S. Sabir, Sara Bandrés‐Ciga et al. · Nature Genetics · 2021 · 448 citations · Full text

Neurodegenerative Diseases, Alzheimer's Disease, Genetics +8